2002Journal of Modern RehabilitationRequires access

Tolterodine in the treatment of idiopathic overactive bladder

Song Hong-ta

Open publisher page 2 citations

Abstract

Objective To examine the safety,efficacy and t olerability of tolterodine in randomized,doubled-blind,3weeks study of patients with idiopathic overactiv e bladder(IOAB).Method Study compared tolterodine(lmg )to oxybutynin(5mg )and placebo taking 2hour before going to bed at night.Changes in micturition diary variables were evaluated after 3weeks' treatment.Result Both tolterodine and oxybutynin significantly decrease d the number of micturiton /lh from baseline,compared to placebo.The most common adverse effect was dry mouth.Tolterodine was tolerated significantly better than oxybutynin when dry mouth(both frequency and intensity)were consid-ered.Conclusion Although oxybutynin is highly effective,its clinical utility is limite d by side effect.Patients receiving tolterodine should not experience hese limitations and instead will get safe and long-term effe ctive treatment.

About this research paper

What this paper is about

Objective To examine the safety,efficacy and t olerability of tolterodine in randomized,doubled-blind,3weeks study of patients with idiopathic overactiv e bladder(IOAB).Method Study compared tolterodine(lmg )to oxybutynin(5mg )and placebo taking 2hour before going to bed at night.Changes in micturition diary variables were evaluated after 3weeks' treatment.Result Both tolterodine and oxybutynin significantly decrease d the number of micturiton /lh from baseline,compared to placebo.The most common adverse effect was dry mouth.Tolterodine was tolerated significantly better than oxybutynin when dry mouth(both frequency and intensity)were consid-ered.Conclusion Although oxybutynin is highly effective,its clinical utility is limite d by side effect.Patients receiving tolterodine should not experience hese limitations and instead will get safe and long-term effe ctive treatment.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To examine the safety,efficacy and t olerability of tolterodine in randomized,doubled-blind,3weeks study of patients with idiopathic overactiv e bladder(IOAB).Method Study compared tolterodine(lmg )to oxybutynin(5mg )and placebo taking 2hour before going to bed at night.Changes in micturition diary variables were evaluated after 3weeks' treatment.Result Both tolterodine and oxybutynin significantly decrease d the number of micturiton /lh from baseline,compared to placebo.The most common adverse effect was dry mouth.Tolterodine was tolerated significantly better than oxybutynin when dry mouth(both frequency and intensity)were consid-ered.Conclusion Although oxybutynin is highly effective,its clinical utility is limite d by side effect.Patients receiving tolterodine should not experience hese limitations and instead will get safe and long-term effe ctive treatment.

Key concepts: Tolterodine, Oxybutynin, Placebo, Overactive bladder, Medicine, Urology, Urination, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Tolterodine in the treatment of idiopathic overactive bladder — Research Paper | ScholarLens